Results 151 to 160 of about 1,504,627 (332)
Evolution of the Membrane Transport Protein Domain. [PDF]
Int J Mol Sci, 2022 Dabravolski SA, Isayenkov SV.
europepmc +1 more source
Ammonia (14C-Methylamine) Transport across the Bacteroid and Peribacteroid Membranes of Soybean Root Nodules [PDF]
, 1990 Michael K. Udvardi, David A. Day
openalex +1 more source
Chitosan–sEPDM and Melatonin–Chitosan–sEPDM Composite Membranes for Melatonin Transport and Release [PDF]
, 2023 Florentina Mihaela Păncescu +9 more
openalex +1 more source
Dual targeting of RET and SRC synergizes in RET fusion‐positive cancer cells
Molecular Oncology, EarlyView.Despite the strong activity of selective RET tyrosine kinase inhibitors (TKIs), resistance of RET fusion‐positive (RET+) lung cancer and thyroid cancer frequently occurs and is mainly driven by RET‐independent bypass mechanisms. Son et al. show that SRC TKIs significantly inhibit PAK and AKT survival signaling and enhance the efficacy of RET TKIs in ...
Juhyeon Son +13 more
wiley +1 more source
Light-Activated Membrane Transport in Polymeric Cell-Mimics. [PDF]
Angew Chem Int Ed Engl, 2022 Cao S, da Silva LC, Landfester K.
europepmc +1 more source
Molecular Oncology, EarlyView.Generation of two normal and tumour (cancerous) paired human cell lines using an established tissue culture technique and their characterisation is described. Cell lines were characterised at cellular, protein, chromosome and gene expression levels and for HPV status.
Simon Broad +12 more
wiley +1 more source
Phospholipid Membrane Transport and Associated Diseases. [PDF]
Biomedicines, 2022 Ventura R +2 more
europepmc +1 more source
A theory for molecular transport phenomena through thin membranes [PDF]
Theory for molecular transport phenomena through thin ...
Lundstrom, T. E.
core +1 more source
Cyclic AMP modulation of ion transport across frog retinal pigment epithelium. Measurements in the short-circuit state. [PDF]
, 1984 In the frog retinal pigment epithelium (RPE), the cellular levels of cyclic AMP (cAMP) were measured in control conditions and after treatment with substances that are known to inhibit phosphodiesterase (PDE) activity (isobutyl-1-methylxanthine, SQ65442)
Farber, D, Miller, S
core